BackgroundCheck.run
Search For

Jeffrey S Borenstein, 5760 Margo Ln, Huntington, NY 11743

Jeffrey Borenstein Phones & Addresses

60 Margo Ln, Huntington, NY 11743    631-7740633   

224 Woodbury Rd, Huntington, NY 11743   

244 Woodbury Rd, Huntington, NY 11743   

Bellmore, NY   

New York, NY   

Saint Louis, MO   

Dix Hills, NY   

Work

Address: 8737 Palermo St, Hollis, NY 11423 Specialities: Psychiatrist

Education

School / High School: New York University 1984

Languages

English

Awards

Healthgrades Honor Roll

Ranks

Certificate: Psychiatry, 1992

Mentions for Jeffrey S Borenstein

Career records & work history

Medicine Doctors

Jeffrey Borenstein Photo 1

Dr. Jeffrey A Borenstein, New York NY - MD (Doctor of Medicine)

Specialties:
Neuropsychiatry (Psychiatry)
Address:
80 E End Ave Suite 16B, New York, NY 10028
Certifications:
Psychiatry, 1992
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
New York University
Graduated: 1984
Jeffrey Borenstein Photo 2

Jeffrey Andrew Borenstein

Specialties:
Psychiatry
Education:
New York University (1984)
Jeffrey Borenstein Photo 3

Jeffrey Andrew Borenstein, Hollis NY

Specialties:
Psychiatrist
Address:
8737 Palermo St, Hollis, NY 11423
Education:
Doctor of Medicine
Board certifications:
American Board of Psychiatry and Neurology Certification in Psychiatry (Psychiatry and Neurology)

Jeffrey Borenstein resumes & CV records

Resumes

Jeffrey Borenstein Photo 23

President

Location:
2475 St south, Bellmore, NY
Industry:
Fine Art
Work:
Sundance Signs Dec 1, 1986 - Nov 14, 2016
President
Interests:
Fourth Degree Black Belt In Jiu Jitsu
Languages:
English
Jeffrey Borenstein Photo 24

Jeffrey Borenstein

Publications & IP owners

Us Patents

Medication-Partnership Program

US Patent:
2003013, Jul 10, 2003
Filed:
Jan 10, 2002
Appl. No.:
10/045485
Inventors:
Jeffrey Borenstein - New York NY, US
Heskia Heskiaoff - New York NY, US
International Classification:
G06F017/60
US Classification:
705/002000
Abstract:
The medication partnership program is a new method of communication between a patient and his/her physician and/or case manager. The invention is a web-based program which enables the physician and case manager to monitor the self report by patients of medication compliance, symptom response, and side effects without a visit to the office. The patient updates information on a daily basis which allows the physician to make appropriate interventions to improve medication compliance and treatment outcome.

Medication-Partnership Program

US Patent:
2003013, Jul 10, 2003
Filed:
Jan 7, 2002
Appl. No.:
10/038458
Inventors:
Jeffrey Borenstein - New York NY, US
Heskia Heskiaoff - New York NY, US
International Classification:
G06F017/60
US Classification:
705/003000
Abstract:
The medication partnership program is a new method of communication between a patient and his/her physician and/or case manager. The invention is a web-based program which enables the physician and case manager to monitor the self report by patients of medication compliance, symptom response, and side effects without a visit to the office. The patient updates information on a daily basis which allows the physician to make appropriate interventions to improve medication compliance and treatment outcome.

Transscleral Drug Delivery Device And Related Methods

US Patent:
2006016, Jul 27, 2006
Filed:
Feb 17, 2004
Appl. No.:
10/545726
Inventors:
Anthony Adamis - Bronxville NY, US
Joan Miller - Winchester MA, US
Mark Mescher - West Newton MA, US
Evangelos Gragoudas - Lexington MA, US
Jeffrey Borenstein - Holliston MA, US
International Classification:
A61M 31/00
US Classification:
604500000
Abstract:
The invention provides a low-profile, dome-shaped body for attachment to a scleral surface of an eye and defining an internal cavity for receiving a drug or other pharmaceutically active agent. The device has an opening for controllably delivering the drug into the eye at therapeutically effective concentrations over a prolonged period of time. When attached, the device does not affect or otherwise restrict movement of the eye. Features of the invention include an optional drug inlet port and puncture guard, both designed for refilling the device while preventing a needle inserted through the inlet port from contacting the sclera.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.